Literature DB >> 21246537

Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.

Fotis Sampsonas1, Dimitrios P Kontoyiannis, Burton F Dickey, Scott E Evans.   

Abstract

BACKGROUND: Flexible bronchoscopy with bronchoalveolar lavage (BAL) is performed widely for the diagnosis of pulmonary infections in patients with cancer, but there is no consensus regarding the technical parameters of the lavage procedure in this setting.
METHODS: The authors evaluated the mechanics (instilled and recovered volumes), diagnostic yield, and safety of a standardized BAL protocol in 284 patients with cancer who underwent bronchoscopy for the evaluation of new radiologic infiltrates.
RESULTS: Physician adherence to the BAL protocol was > 90%. The most common protocol deviations were reductions in the saline volume instilled because of actual or anticipated oxyhemoglobin desaturation during the procedure. The mean volume instilled was 121.5 ± 13.9 mL, the mean volume recovered was 68.7 ± 18.1 mL, and the mean ratio of volume instilled to that recovered was 56.7% ± 14.5%. The overall diagnostic yield of BAL was 33.8% and was higher in the nonhematologic malignancy group (42.3% vs 29.4%; P = .021). The diagnostic yield in neutropenic patients was significantly higher than in non-neutropenic patients (41.5% vs 24.6%; P = .019). No major complications were encountered.
CONCLUSIONS: In summary, the diagnostic performance of a standardized BAL protocol was comparable to that of nonprotocolized BAL reported in the literature with few complications. Adherence to a standardized BAL protocol may improve clinical and laboratory comparisons between studies, potentially facilitating research into the diagnosis and management of pneumonia in patients with cancer.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21246537      PMCID: PMC3457647          DOI: 10.1002/cncr.25905

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Culturing bronchial washings obtained during bronchoscopy fails to add diagnostic utility to culturing the bronchoalveolar lavage fluid alone.

Authors:  J Keith Pinckard; Marin Kollef; W Micheal Dunne
Journal:  Diagn Microbiol Infect Dis       Date:  2002-06       Impact factor: 2.803

Review 2.  Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group.

Authors: 
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

Review 3.  Clinical role of bronchoalveolar lavage in adults with pulmonary disease.

Authors:  R A Goldstein; P K Rohatgi; E H Bergofsky; E R Block; R P Daniele; D R Dantzker; G S Davis; G W Hunninghake; T E King; W J Metzger
Journal:  Am Rev Respir Dis       Date:  1990-08

4.  Pulmonary candidiasis in patients with cancer: an autopsy study.

Authors:  D P Kontoyiannis; B T Reddy; H A Torres; M Luna; R E Lewis; J Tarrand; G P Bodey; I I Raad
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

5.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

6.  Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates.

Authors:  Prasoon Jain; Sunder Sandur; Yvonne Meli; Alejandro C Arroliga; James K Stoller; Atul C Mehta
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

7.  Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Georg Maschmeyer; Thomas Beinert; Dieter Buchheidt; Hermann Einsele; Claus Peter Heussel; Michael Kiehl; Joachim Lorenz
Journal:  Ann Hematol       Date:  2003-09-09       Impact factor: 3.673

8.  Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures.

Authors:  M von Eiff; M Zühlsdorf; N Roos; M Thomas; T Büchner; J van de Loo
Journal:  Eur J Haematol       Date:  1995-03       Impact factor: 2.997

9.  Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation.

Authors:  C Cordonnier; J F Bernaudin; J Fleury; M Feuilhade; C Haioun; D Payen; Y Huet; K Atassi; J P Vernant
Journal:  Am Rev Respir Dis       Date:  1985-11

10.  The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer.

Authors:  Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

View more
  20 in total

Review 1.  Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.

Authors:  Dimitrios P Kontoyiannis; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2014-11-15       Impact factor: 9.079

Review 2.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

Review 3.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  Pneumonia in the neutropenic cancer patient.

Authors:  Scott E Evans; David E Ost
Journal:  Curr Opin Pulm Med       Date:  2015-05       Impact factor: 3.155

5.  Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.

Authors:  A Fernández-Cruz; E Magira; S T Heo; S Evans; J Tarrand; D P Kontoyiannis
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 6.  How I treat mucormycosis.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

7.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

8.  Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases.

Authors:  Ana Fernández-Cruz; Laura Ortega; Gonzalo García; Iria Gallego; Ana Álvarez-Uría; Esther Chamorro-de-Vega; José Javier García-López; Ricardo González-Del-Val; Pablo Martín-Rabadán; Carmen Rodríguez; María Luisa Pedro-Botet; Miguel Martín; Emilio Bouza
Journal:  Oncologist       Date:  2020-02-11

9.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

10.  American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.

Authors:  Sanjeet S Dadwal; Tobias M Hohl; Cynthia E Fisher; Michael Boeckh; Genofeva Papanicolaou; Paul A Carpenter; Brian T Fisher; Monica A Slavin; D P Kontoyiannis
Journal:  Transplant Cell Ther       Date:  2021-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.